Initiation of Type 2 Diabetes Mellitus Medications in the NGHA Healthcare System in Saudi Arabia: Contemporary Trends
The initiation of novel antidiabetic medications has increased over the study period, reflecting recent updates in T2DM management guidelines. However, further understanding of their benefits is required for optimal patient care.
Authors
- Anwar H. Alqarni
- Lujain Abdulaziz ALMOUSA (ORCID: https://orcid.org/0000-0002-7968-418X)
- Lubna Alnasser (ORCID: https://orcid.org/0009-0004-1442-5293)
- Adel F. Almutairi (ORCID: https://orcid.org/0000-0003-0015-9524)
- Mesnad Alyabsi (ORCID: https://orcid.org/0000-0001-7763-9572)
- Asma Aldawsari
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdullah International Medical Research Center (SA)
Publication Details
- Journal
- Current Therapeutic Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.curtheres.2025.100809
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00